jili 178 register philippines
Furthermore, the establishment of specific guidelines for evidence of domestic violence can enhance the coordination and collaboration among different agencies and organizations involved in supporting victims and addressing abuse. With a common understanding of what constitutes valid evidence, stakeholders can work together more effectively to provide comprehensive services and resources to those in need.TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)As the transfer window approaches, all eyes will be on Manchester United to see what decision they make regarding Marcus Rashford's future. With Ruben Amorim's admiration for the player adding to the intrigue, the speculation is likely to continue until a final resolution is reached. Whether Rashford stays at Old Trafford or moves on to new pastures, one thing is certain: his talent and potential will ensure that he remains a player to watch in the world of football.
On the other hand, JD.com, the powerhouse of online retail, is focusing on its reputation for quality and reliability. With a strong logistics network and commitment to authenticity, JD.com is positioning itself as a trusted platform for consumers seeking genuine products. The company is also emphasizing its omni-channel strategy, offering seamless shopping experiences across online and offline channels, further enhancing the convenience for shoppers.
Roivios Initiates Landmark Study to Demonstrate Safety and Efficacy of an Innovative Renal Assist Device for Cardiac Surgery Patients With Kidney Disease NASSAU, Bahamas , Dec. 19, 2024 /PRNewswire/ -- Roivios , a pioneering clinical-stage medical device company dedicated to revolutionizing kidney health, proudly announces that its research and development arm, 3ive Labs, has secured approval for an Investigational Device Exemption (IDE) from the FDA. This approval paves the way for a pivotal trial of the JuxtaFlow Renal Assist Device (RAD), marking a transformative step forward in enhancing outcomes for cardiac surgery patients with renal insufficiency. The GRADIENT ( G roundbreaking R enal A ssist D evice I ntervening to EN hance cardio T horacic surgery outcomes) trial is designed to address the critical need for renal support among cardiac surgery patients undergoing cardiopulmonary bypass (CPB). These patients often face increased risks of postoperative complications, such as worsening renal dysfunction, which can lead to extended ICU stays and increased mortality. "The GRADIENT Trial offers an invaluable opportunity to further explore renal support during cardiac surgery," said Dr. Evelio Rodriguez , a renowned heart surgeon at Ascension Saint Thomas in Nashville, TN , and the National Principal Investigator of the GRADIENT trial. "The JuxtaFlow device offers new hope for some of our most vulnerable patients." JuxtaFlow RAD is an innovative device designed to potentially improve kidney function during times of acute stress. By applying a gentle suction to the kidney's outlet, it aims to enhance blood filtration more efficiently. This groundbreaking approach was recognized with an FDA Breakthrough Device Designation in April. The GRADIENT study will be a prospective, multicenter, randomized, controlled, open-label trial that plans to enroll patients with renal insufficiency (eGFR 15-60 ml/min) undergoing elective or urgent cardiac surgery requiring CPB. The study seeks to evaluate the safety and effectiveness of the JuxtaFlow RAD to sustain or enhance renal function during and following CPB surgery. "Achieving Breakthrough Device Designation was instrumental in securing IDE approval," noted John Erbey , Chief Executive Officer at Roivios. "This initiative is the culmination of a decade of technological and clinical advancements in addressing kidney disease management challenges. Our ongoing dialogue with the FDA is paving the way for more effective management, empowering patients to thrive. We are eager to commence IDE enrollment and explore the JuxtaFlow RAD's potential to improve surgical outcomes and enhance patient quality of life." For more information about Roivios and the JuxtaFlow Renal Assist Device, please visit Roivios.com . About JuxtaFlow RAD The JuxtaFlow RAD is a pioneering investigational device set to transform kidney support therapy. Acknowledging the harmful effects of fluid accumulation and pressure on the kidneys, Roivios has advanced beyond traditional blood filtration methods that can further stress the kidneys. By applying mild, controlled negative pressure within the kidney's collecting system, the device has the potential to maintain and improve filtration and support recovery. This novel approach holds promise for a compelling value proposition by preserving kidney function and expediting patient recovery, ultimately reducing hospital stays and associated costs. Equipped with a proprietary specialized catheters and pump, the device optimizes kidney function during critical recovery periods, such as post-surgery. Currently, the JuxtaFlow RAD is under investigation and is not available for sale in any geography. About Roivios Roivios is a clinical-stage medical device company committed to pioneering solutions for kidney health. Our lead product, the JuxtaFlow Renal Assist Device (RAD), is designed to preserve kidney function and offer a proactive approach to managing kidney disease. We aim to demonstrate improved renal outcomes, potentially reducing the need for dialysis, and lowering healthcare costs. Holding proprietary patents in key kidney technologies, we aim to revolutionize kidney disease management. With plans to extend its application beyond kidney disease to various medical settings, Roivios is preparing for a transformative U.S. launch, aiming to redefine kidney disease management and improve patient quality of life. Discover more at roivios.com . This release contains forward-looking statements subject to risks and uncertainties. Actual results may differ significantly. Media Contact : Kelly Krueger , Krueger PR, kelly@kruegerpr.com View original content to download multimedia: https://www.prnewswire.com/news-releases/fda-grants-ide-approval-for-the-pivotal-trial-of-the-juxtaflow-renal-assist-device-rad-302336698.html SOURCE Roivios, ltd
For some individuals, coffee can irritate the digestive system and lead to issues such as acid reflux, heartburn, and upset stomach. By cutting out coffee, you may experience relief from these digestive complaints and improve your overall gut health. Additionally, quitting coffee can help regulate bowel movements and reduce the risk of dehydration often associated with excessive caffeine consumption.
Matt Gaetz Says He Won't Return to Congress Next Year After Withdrawing Name for Attorney General
In the midst of the craze surrounding the popular Chinese drama series "I Am a Detective," a peculiar and controversial incident has recently grabbed the attention of many netizens. A self-proclaimed blogger came forward online, identifying themselves as the "lover of Zhou Kehua," a notorious criminal who was once one of China's most wanted fugitives. This bold claim immediately sparked a wave of curiosity and outrage, prompting legal professionals to step in and investigate the validity of the statement.In terms of trade volumes, China's export and import figures have shown resilience and strength throughout the year. Despite fluctuations in global demand and supply chain disruptions, China's exports have remained robust, driven by strong demand for electronics, textiles, and medical equipment. Meanwhile, imports have also increased, reflecting growing domestic consumption and investment activities.
Uwharrie Ridge reinforces focus on career pathwaysPrince Harry Gets Candid at “New York Times' ”DealBook Summit: 'One of My Biggest Weaknesses Is Feeling Helpless'The annual Double 12 shopping festival has kicked off with a bang, and e-commerce giants such as Taobao, JD.com, TikTok, Pinduoduo, as well as traditional retailer Suning, are all gearing up to showcase their respective strengths in capturing the attention of Chinese consumers. Dubbed as China's answer to the famous Singles' Day shopping bonanza, Double 12 is set to ignite the retail landscape with a flurry of discounts, promotions, and deals across various online platforms.
LITTLE ROCK, Ark. , Dec. 19, 2024 /PRNewswire/ -- Forge Institute is proud to announce the launch of the Phoenix Xcelerator, a pioneering program designed to empower & grow startups across the defense and aerospace sectors. Through structured programming—including a rigorous high-quality curriculum, personalized mentorship, and coaching—the Phoenix Xcelerator advances industry-informed and mission-led innovation. The program is funded in-part through a grant from the Arkansas Economic Development Commission (AEDC). Why Arkansas ? Arkansas is home to over 178 aerospace and defense companies employing more than 10,900 people. Reports from federal sources highlight a decline in defense contractors, with the Department of Defense (DoD) vendors shrinking by 27.6% in the past decade. The Phoenix Xcelerator aims to reverse this trend, empowering startups to address defense challenges and reinforcing Arkansas's leadership in the sector. Arkansas's aerospace and defense exports, valued at over $850 million in 2023, represent 13% of the state's total exports, making them the top export category. Furthermore, the Little Rock Air Force Base reported a $1.38 billion economic impact in 2023. Major players like Lockheed Martin, Raytheon, and Dassault Falcon Jet have positioned the state as a hub for defense innovation, with the Phoenix Xcelerator serving as a launchpad for the next wave of industry leaders. Program Details The Phoenix Xcelerator offers a 12-week intensive program, guiding participants through business validation, go-to-market strategies, and development of minimum viable products (MVPs) or prototypes. Participants gain expertise in non-dilutive funding opportunities such as SBIR/STTR and other grant programs, as well as access to capital networks for sustained growth. Established companies receive support in maximizing intellectual property and evaluating dual-use markets. Key features include: The program emphasizes emerging technologies like directed energy, artificial intelligence, cybersecurity, drones, ISR and other technologies, ensuring readiness for critical defense challenges. Apply Now The Phoenix Xcelerator team brings decades of expertise to guide startups toward impactful, scalable growth. Entrepreneurs and companies working on dual-use technologies are encouraged to apply, gaining unparalleled resources and opportunities to innovate within the defense sector. To apply now, visit www.forge.institute/phoenix-xcelerator View original content to download multimedia: https://www.prnewswire.com/news-releases/forge-institute-launches-phoenix-xcelerator-to-scale-growth-of-defense-tech-startups-302336707.html SOURCE Forge Institute
Trump calls for end to 'spring forward, fall back' clock changes
- Previous: jili 178 register login download
- Next:
